5-Fluoro-AMT
From Wikipedia, the free encyclopedia
(Redirected from 5-Fluoro-αMT)
Jump to: navigation, search
![]() |
|
![]() |
|
Identifiers | |
---|---|
|
|
CAS Number | 712-08-3 ![]() |
PubChem (CID) | 12834 |
ChemSpider | 12304 ![]() |
ChEMBL | CHEMBL96816 ![]() |
Chemical and physical data | |
Formula | C11H13FN2 |
Molar mass | 192.233 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
![]() ![]() |
5-Fluoro-α-methyltryptamine (5-Fluoro-αMT), also known as PAL-544,[1] is a putative stimulant, entactogen, and psychedelic tryptamine derivative related to α-methyltryptamine (αMT). It has been found to act as a well-balanced serotonin-norepinephrine-dopamine releasing agent,[1] a 5-HT2A receptor agonist,[2] and a potent and specific MAO-A inhibitor.[3][4] It produces a strong head-twitch response in mice, and this effect is known to correlate with psychedelic effects in humans,[5][6] which suggests that 5-fluoro-αMT could be an active psychedelic in humans, although it is not known to have been tested in humans and could be dangerous due to its strong inhibition of MAO-A.
See also[edit]
- 5-Chloro-αMT
- 5-Fluoro-DMT
- 7-Methyl-αET
- Flucindole
- 5-API (PAL-571)
References[edit]
- ^ a b Banks, M. L.; Bauer, C. T.; Blough, B. E.; Rothman, R. B.; Partilla, J. S.; Baumann, M. H.; Negus, S. S. (2014). "Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys". Experimental and Clinical Psychopharmacology. 22 (3): 274–84. doi:10.1037/a0036595. PMC 4067459
. PMID 24796848.
- ^ Chairungsrilerd, N; Furukawa, K; Tadano, T; Kisara, K; Ohizumi, Y (Mar 1998). "Effect of gamma-mangostin through the inhibition of 5-hydroxy-tryptamine2A receptors in 5-fluoro-alpha-methyltryptamine-induced head-twitch responses of mice". British Journal of Pharmacology. 123 (5): 855–62. doi:10.1038/sj.bjp.0701695. PMC 1565246
. PMID 9535013.
- ^ Kinemuchi, H; Arai, Y (Oct 1986). "Selective inhibition of monoamine oxidase A and B by two substrate-analogues, 5-fluoro-alpha-methyltryptamine and p-chloro-beta-methylphenethylamine". Research Communications in Chemical Pathology and Pharmacology. 54 (1): 125–8.
- ^ Kim, SK; Toyoshima, Y; Arai, Y; Kinemuchi, H; Tadano, T; Oyama, K; Satoh, N; Kisara, K (Apr 1991). "Inhibition of monoamine oxidase by two substrate-analogues, with different preferences for 5-hydroxytryptamine neurons". Neuropharmacology. 30 (4): 329–35. doi:10.1016/0028-3908(91)90057-i. PMID 1852266.
- ^ Corne, SJ; Pickering, RW (1967). "A possible correlation between drug induced hallucinations in man and a behavioral response in mice". Psychopharmacologia. 11 (1): 65–78. doi:10.1007/bf00401509. PMID 5302272.
- ^ Yamamoto, T; Ueki, S (Jan 1981). "The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by halluinogenic drugs". Pharmacology, Biochemistry and Behaviour. 1981 (14): 89–95. doi:10.1016/0091-3057(81)90108-8. PMID 6258178.
Further reading[edit]
- Nakagawasai, O; et al. (Jan 2004). "Monoamine oxidase and head-twitch response in mice. Mechanisms of alpha-methylated substrate derivatives". Neurotoxicology. 25 (1-2): 223–32. doi:10.1016/S0161-813X(03)00101-3. PMID 14697897. CS1 maint: Explicit use of et al. (link)
Phenylalkyl- amines (other than cathinones) |
|
---|---|
Cyclized phenyl- alkylamines |
|
Cathinones | |
Tryptamines | |
Chemical classes |
Adamantanes | |
---|---|
Adenosine antagonists | |
Alkylamines | |
Ampakines | |
Arylcyclohexylamines | |
Benzazepines | |
Cholinergics |
|
Convulsants | |
Eugeroics | |
Oxazolines | |
Phenethylamines |
|
Phenylmorpholines | |
Piperazines | |
Piperidines |
|
Pyrrolidines | |
Racetams | |
Tropanes |
|
Tryptamines | |
Others |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
![]() |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Articles with changed CASNo identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- CS1 maint: Explicit use of et al.
- All stub articles